Cold agglutinin disease.Br J Haematol 2026 Aug; 209(2):444-447.BJ
Abstract
Cold agglutinin disease is an autoimmune haemolytic anaemia related to a clonal B-cell disorder of the bone marrow. Haemolysis is complement-dependent, while acrocyanosis is monoclonal agglutinin-dependent. Established therapies target the clonal B cells or the classical complement pathway. Treatment can be tailored based on clinical phenotypes.
Links
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
42144314
Citation
Berentsen, Sigbjørn, and Josephine M I. Vos. "Cold Agglutinin Disease." British Journal of Haematology, vol. 209, no. 2, 2026, pp. 444-447.
Berentsen S, Vos JMI. Cold agglutinin disease. Br J Haematol. 2026;209(2):444-447.
Berentsen, S., & Vos, J. M. I. (2026). Cold agglutinin disease. British Journal of Haematology, 209(2), 444-447. https://doi.org/10.1111/bjh.70570
Berentsen S, Vos JMI. Cold Agglutinin Disease. Br J Haematol. 2026;209(2):444-447. PubMed PMID: 42144314.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Cold agglutinin disease.
AU - Berentsen,Sigbjørn,
AU - Vos,Josephine M I,
Y1 - 2026/05/17/
PY - 2026/02/28/received
PY - 2026/05/08/accepted
PY - 2026/8/12/medline
PY - 2026/5/18/pubmed
PY - 2026/5/17/entrez
KW - autoimmune haemolytic anaemia
KW - clinical phenotypes
KW - cold agglutinin disease
KW - complement
KW - therapy
SP - 444
EP - 447
JF - British journal of haematology
JO - Br J Haematol
VL - 209
IS - 2
N2 - Cold agglutinin disease is an autoimmune haemolytic anaemia related to a clonal B-cell disorder of the bone marrow. Haemolysis is complement-dependent, while acrocyanosis is monoclonal agglutinin-dependent. Established therapies target the clonal B cells or the classical complement pathway. Treatment can be tailored based on clinical phenotypes.
SN - 1365-2141
UR - https://www.unboundmedicine.com/prime/citation/42144314/Cold_agglutinin_disease.
DB - PRIME
DP - Unbound Medicine
ER -
